AR058509A1 -
MACROLONE COMPOUND OF ERYTHROMYCIN, ITS USE TO PREPARE A MEDICINAL PRODUCT AND PHARMACEUTICAL COMPOSITION THAT INCLUDES IT
- Google Patents
MACROLONE COMPOUND OF ERYTHROMYCIN, ITS USE TO PREPARE A MEDICINAL PRODUCT AND PHARMACEUTICAL COMPOSITION THAT INCLUDES IT
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group LtdfiledCriticalGlaxo Group Ltd
Priority to ARP060104883ApriorityCriticalpatent/AR058509A1/en
Publication of AR058509A1publicationCriticalpatent/AR058509A1/en
Uso del mismo para preparar un medicamento para el tratamiento o profilaxis de infecciones microbianas sistémicas o topicas en el cuerpo de un ser humano o animal y composicion farmacéutica que lo comprende. Reivindicacion 1:Un compuesto macrolona de eritromicina caracterizado porque es de la formula (1) y/o derivados farmacéuticamente aceptables del mismo.Use thereof to prepare a medicament for the treatment or prophylaxis of systemic or topical microbial infections in the body of a human or animal being and pharmaceutical composition comprising it. Claim 1: A macrolone compound of erythromycin characterized in that it is of the formula (1) and / or pharmaceutically acceptable derivatives thereof.
ARP060104883A2006-11-072006-11-07
MACROLONE COMPOUND OF ERYTHROMYCIN, ITS USE TO PREPARE A MEDICINAL PRODUCT AND PHARMACEUTICAL COMPOSITION THAT INCLUDES IT
AR058509A1
(en)
DERIVATIVES OF 2,3-DIHYDROIMIDOZO [1,2-C] QUINIZOLINA SUBSTITUTED FOR USE IN THE TREATMENT OF HYPERPROLIFERATIVE DISORDERS AND DISEASES ASSOCIATED WITH ANGIOGENESIS
Derivatives of 2,3-dihydroimidazo [1,2-c] quinazoline substituted with amino alcohols that are useful for treating hyperproliferative disorders and diseases associated with angiogenesis
USE OF A STROGEN FOR THE TREATMENT OF DISEASES, CONDITIONS OR SYMPTOMS ASSOCIATED WITH DEFICIENT LEVELS OF STROGENS IN A WOMAN; PHARMACEUTICAL COMPOSITION THAT INCLUDES DAILY DOSAGE UNITS OF ESTRADIOL HEMIDRATE> 0.75 AND 1
Formulation comprising triazinones and compounds or ferric complexes, useful for preparing medicines for veterinary use against coccidiosis and iron deficiencies.